Phone app could ease distress in breast cancer survivors

NCT ID NCT04583891

Completed Symptom relief Sponsor: University of Virginia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a mobile app called IntelliCare can reduce depression and anxiety in breast cancer survivors. 313 women who had been diagnosed within the past 5 years and had elevated symptoms used the app or received standard educational materials. The study also looked at whether adding human coaching helped those who used the app less. The goal is to find a low-cost, accessible way to support survivors' mental health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: IntelliCare mobile app suite
What this could lead to: If it works, this could provide a simple, scalable way to help breast cancer survivors manage emotional distress using their phone.
What could go wrong: This is a completed study, but it tested a behavioral intervention, not a drug. Results may not apply to all survivors, and the effect may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder breast cancer breast neoplasm Depression mixed anxiety and depressive disorder Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION, ANXIETY ENGAGEMENT, PATIENT

Contacts and locations

Locations

University of Virginia

Charlottesville, Virginia, 22904, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.